Max Wang

805 total citations
37 papers, 593 citations indexed

About

Max Wang is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Surgery. According to data from OpenAlex, Max Wang has authored 37 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Immunology and 6 papers in Surgery. Recurrent topics in Max Wang's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Lipoproteins and Cardiovascular Health (3 papers). Max Wang is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Lipoproteins and Cardiovascular Health (3 papers). Max Wang collaborates with scholars based in United States, China and Australia. Max Wang's co-authors include Yadong Huang, Leslie M. Tong, Seo Yeon Yoon, Donald L. Whitfill, Dale E. Jamison, Daniel H. Kim, Anna G. Orr, Kaitlyn Ho, Edward C. Hsiao and Lennart Mucke and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Circulation.

In The Last Decade

Max Wang

35 papers receiving 585 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Max Wang United States 10 234 163 139 108 88 37 593
Fen Huang China 10 213 0.9× 127 0.8× 57 0.4× 260 2.4× 11 0.1× 15 553
Tetsuya Sasaki Japan 17 141 0.6× 80 0.5× 42 0.3× 251 2.3× 67 0.8× 41 653
Penghui Chen China 14 51 0.2× 27 0.2× 114 0.8× 150 1.4× 49 0.6× 55 577
Wenqin Cai China 21 334 1.4× 120 0.7× 119 0.9× 258 2.4× 40 0.5× 67 1.0k
Tianfu Li United States 10 551 2.4× 190 1.2× 128 0.9× 329 3.0× 364 4.1× 16 1.1k
Yunna Li China 10 64 0.3× 77 0.5× 160 1.2× 155 1.4× 22 0.3× 22 485
Wangming Zhang China 14 200 0.9× 21 0.1× 40 0.3× 108 1.0× 4 0.0× 49 503
Junki Yamamoto Japan 11 144 0.6× 152 0.9× 271 1.9× 95 0.9× 7 0.1× 31 711
Sadaharu Tabuchi Japan 15 215 0.9× 76 0.5× 68 0.5× 173 1.6× 9 0.1× 42 721

Countries citing papers authored by Max Wang

Since Specialization
Citations

This map shows the geographic impact of Max Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Wang more than expected).

Fields of papers citing papers by Max Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Wang. The network helps show where Max Wang may publish in the future.

Co-authorship network of co-authors of Max Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Max Wang. A scholar is included among the top collaborators of Max Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Wang. Max Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Cheng-Yen, John Knight, S B Hawley, et al.. (2025). Sialidase fusion protein protects against influenza infection in a cigarette smoke-induced model of COPD. Mucosal Immunology. 18(2). 467–480. 2 indexed citations
2.
Zhang, Yanyan, Zhaohui Pei, Xiaolin Dong, et al.. (2024). Ebronucimab in Chinese patients with hypercholesterolemia---A randomized double-blind placebo-controlled phase 3 trial to evaluate the efficacy and safety of ebronucimab. Pharmacological Research. 207. 107340–107340. 3 indexed citations
3.
Stojanova, Jana, Max Wang, Jan Roggeveld, et al.. (2024). A potential novel treatment for cirrhosis‐related ascites: Empagliflozin is safe and tolerable in advanced chronic liver disease. British Journal of Clinical Pharmacology. 90(10). 2529–2538. 3 indexed citations
4.
5.
Bellomo, Tiffany R., Max Wang, Katherine I. Wolf, et al.. (2023). Analysis of Female Participant Representation in Registered Oncology Clinical Trials in the United States from 2008 to 2020. The Oncologist. 28(6). 510–519. 9 indexed citations
6.
7.
Fecho, Karamarie, Stanley C. Ahalt, Ashok Krishnamurthy, et al.. (2022). Leveraging Open Electronic Health Record Data and Environmental Exposures Data to Derive Insights Into Rare Pulmonary Disease. Frontiers in Artificial Intelligence. 5. 918888–918888. 1 indexed citations
8.
Li, Qian, Ju Qiao, Hongzhong Jin, et al.. (2022). Population pharmacokinetic/pharmacodynamic analysis of AK111, an IL-17A monoclonal antibody, in subjects with moderate-to-severe plaque psoriasis. Frontiers in Pharmacology. 13. 966176–966176. 1 indexed citations
9.
10.
11.
Bellomo, Tiffany R., Ruxandra Ionescu, Max Wang, et al.. (2021). Female participation in U.S. oncology clinical trials registered on ClinicalTrials.gov from 2008 to 2020.. Journal of Clinical Oncology. 39(28_suppl). 85–85. 1 indexed citations
12.
Turner, Brandon E., Bonnie O. Wong, Tiffany R. Bellomo, et al.. (2021). The surgical oncology clinical trial landscape: A cross-sectional analysis of ClinicalTrials.gov from 2008-2020.. Journal of Clinical Oncology. 39(15_suppl). 1561–1561.
13.
14.
Shenoi, Sheela, Ravesh Singh, Max Wang, et al.. (2019). Low expression Macrophage Migration Inhibitory Factor (MIF) alleles and tuberculosis in HIV infected South Africans. SHILAP Revista de lepidopterología. 1(1). 100004–100004. 4 indexed citations
15.
Chang, Ting Chia, Max Wang, & Amin Arbabian. (2019). Multi-Access Networking with Wireless Ultrasound-Powered Implants. PubMed. 2019. 1–4. 8 indexed citations
16.
Cavelti‐Weder, Claudia, Weida Li, Adrian Zumsteg, et al.. (2015). Hyperglycaemia attenuates in vivo reprogramming of pancreatic exocrine cells to beta cells in mice. Diabetologia. 59(3). 522–532. 23 indexed citations
17.
Orr, Anna G., Edward C. Hsiao, Max Wang, et al.. (2015). Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory. Nature Neuroscience. 18(3). 423–434. 206 indexed citations
18.
Tong, Leslie M., Biljana Djukic, Christine Arnold, et al.. (2014). Inhibitory Interneuron Progenitor Transplantation Restores Normal Learning and Memory in ApoE4 Knock-In Mice without or with Aβ Accumulation. Journal of Neuroscience. 34(29). 9506–9515. 90 indexed citations
19.
Andrews‐Zwilling, Yaisa, Seo Yeon Yoon, Sachi Jain, et al.. (2012). Apolipoprotein E4 Causes Age- and Sex-Dependent Impairments of Hilar GABAergic Interneurons and Learning and Memory Deficits in Mice. PLoS ONE. 7(12). e53569–e53569. 87 indexed citations
20.
Whitfill, Donald L., et al.. (2007). Preventing Lost Circulation Requires Planning Ahead. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fen Huang Breakdown of academic impact, for papers by Tetsuya Sasaki Breakdown of academic impact, for papers by Penghui Chen Breakdown of academic impact, for papers by Wenqin Cai Breakdown of academic impact, for papers by Tianfu Li Breakdown of academic impact, for papers by Yunna Li Breakdown of academic impact, for papers by Wangming Zhang Breakdown of academic impact, for papers by Junki Yamamoto Breakdown of academic impact, for papers by Sadaharu Tabuchi
Rankless by CCL
2026